GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (FRA:L020) » Definitions » LT-Debt-to-Total-Asset

Britannia Life Sciences (FRA:L020) LT-Debt-to-Total-Asset : 0.21 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Britannia Life Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Britannia Life Sciences's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.21.

Britannia Life Sciences's long-term debt to total assets ratio declined from Dec. 2023 (0.23) to Dec. 2024 (0.21). It may suggest that Britannia Life Sciences is progressively becoming less dependent on debt to grow their business.


Britannia Life Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Britannia Life Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences LT-Debt-to-Total-Asset Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24
LT-Debt-to-Total-Asset
0.12 0.01 0.27 0.23

Britannia Life Sciences Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.23 0.21 0.22 0.21

Britannia Life Sciences LT-Debt-to-Total-Asset Calculation

Britannia Life Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )/Total Assets (A: Mar. 2024 )
=3.439/15.131
=0.23

Britannia Life Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=3.115/14.859
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Britannia Life Sciences  (FRA:L020) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Britannia Life Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Britannia Life Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Britannia Life Sciences Business Description

Traded in Other Exchanges
Address
120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally.

Britannia Life Sciences Headlines

No Headlines